Norwegian Doctor Claims To Find Link Between AstraZeneca Vaccine And Rare Blood Clots

Norwegian Doctor Claims To Find Link Between AstraZeneca Vaccine And Rare Blood Clots

As we wait for the EMA’s decision, a top Norwegian health official tasked with investigating a series of three high-profile cases of health-care workers under the age of 50 being hospitalized for similar cases of rare blood clots after receiving the AstraZeneca vaccine have proposed a theory that’s bound to infuriate AstraZeneca, along with the EMA and WHO.

Chief physician and professor Pål Andre Holme told Norwegian papers on Thursday, just hours before the EMA was set to release the findings of its promised “safety review” (which was conducted even more hastily than the initial vaccine studies), that he has a new theory about what caused the reactions in the health workers, and unfortunately, per Holme, the AstraZeneca jab acted as the trigger.

“The reason for the condition of our patients has been found,” chief physician and professor Pål Andre Holme announced to Norwegian national newspaper VG today.

He has lead the work to find out why three health workers under the age of 50 were hospitalized with serious blood clots and low levels of blood platelets after having taken the AstraZeneca Covid vaccine. One of the health workers died on Monday.

The experts have worked on a theory that it was in fact the vaccine which triggered and unexpected and powerful immune response – a theory they now believe they have confirmed.

“Our theory that this is a powerful immune response which most likely was caused by the vaccine has been found. In collaboration with experts in the field from the University Hospital of North Norway HF, we have found specific antibodies against blood platelets that can cause these reactions, and which we know from other fields of medicine, but then with medical drugs as the cause of the reaction,” the chief physician explains to VG.

Though he acknowledged the theory was just that – a theory, Holme insisted there was nothing else that could have triggered such an intense immune response in all three patients. The vaccine was the only common factor.

When asked to clarify why he says “most likely” in the quote, Holme confidently responds that the reason for these rare cases of blood clots has been found.

“We have the reason. Nothing but the vaccine can explain why these individuals had this immune response,” he states.

VG also asks how Holme can know that the immune response is not caused by something other than the vaccine.

“There is nothing in the patient history of these individuals that can give such a powerful immune response. I am confident that the antibodies that we have found are the cause, and I see no other explanation than it being the vaccine which triggers it,” he responds.

Notably, the Norwegian Medicines Agency doesn’t wish to comment on the conclusions from Oslo University Hospital: “We have to look at the results first, I don’t want to comment on this now,” said Medical Director Steinar Madsen in a statement to the Norwegian News Agency.

More than 2 dozen cases of the rare blood clots have been reported, by local authorities have pointed to a potential link between patients with low blood-platelet counts. Still, after about 10M doses, the number of confirmed blood-clot incidents is just over 25. Those are some pretty low odds.

For those confused about the nature of the problem, Dr. John Weiner breaks it down: the issue, as Holme explained, is a specific type of dangerous clot that has occurred.

Not that the “abundance of caution” approach isn’t warranted. After what happened last year as big tech censored anybody speaking out against the official COVID narratives on masks and lockdowns, we wonder when Twitter and Facebook will move to censor Holme. Notably, it appears the international press has seemingly passed on the story, despite more reports of blood clots hitting Thursday morning as we await the EMA report.

Tyler Durden
Thu, 03/18/2021 – 08:52

Share DeepPol